CMO Jeffrey Giullian, M.D., M.B.A., describes how DaVita is using machine learning to improve outcomes for those receiving dialysis at home
DaVita Algorithm Flags Issues With Home Dialysis Patients
April 15, 2026
- Employer-Sponsored Health Insurance 101
- Eli Lilly Buys Startup CrossBridge Bio to Bring a More Powerful Strike to Tumors
- Implications of AI Chatbots Performing Poorly at Differential Diagnosis
- From Insight to Intervention: Why Over-the-Counter Digital Therapeutics (ODTx) are the Next Step for LLMs and Wearables
Headlines
